{"id":"celecoxib-celebrex","safety":{"commonSideEffects":[{"rate":"8-15","effect":"Dyspepsia"},{"rate":"5-10","effect":"Abdominal pain"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"5-10","effect":"Headache"},{"rate":"2-5","effect":"Hypertension"},{"rate":"1-2","effect":"Cardiovascular events (myocardial infarction, stroke)"}]},"_chembl":{"chemblId":"CHEMBL118","moleculeType":"Small molecule","molecularWeight":"381.38"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a selective COX-2 inhibitor, celecoxib blocks the COX-2 enzyme preferentially over COX-1, thereby decreasing inflammatory prostaglandins while theoretically sparing the protective prostaglandins produced by COX-1 in the gastrointestinal tract. This selectivity was designed to provide anti-inflammatory and analgesic effects with a potentially improved gastrointestinal safety profile compared to non-selective NSAIDs.","oneSentence":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:17:40.761Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain"},{"name":"Primary dysmenorrhea"},{"name":"Familial adenomatous polyposis (FAP)"}]},"trialDetails":[{"nctId":"NCT07435077","phase":"PHASE4","title":"Examining Analgesic Synergy and Efficacy in Trauma Care","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":282},{"nctId":"NCT03818932","phase":"PHASE2, PHASE3","title":"Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2019-01-22","conditions":"Anterior Cruciate Ligament Injury","enrollment":90},{"nctId":"NCT02115074","phase":"PHASE1","title":"Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2014-06","conditions":"Glioma","enrollment":20},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT05731726","phase":"PHASE2","title":"Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2023-02-22","conditions":"pMMR, MSS, MSI-L","enrollment":50},{"nctId":"NCT03026140","phase":"PHASE2","title":"Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-03-29","conditions":"Colon Carcinoma","enrollment":353},{"nctId":"NCT04469530","phase":"PHASE2","title":"Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-09-16","conditions":"Solid Tumor","enrollment":55},{"nctId":"NCT04093323","phase":"PHASE2","title":"Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-11-13","conditions":"HLA-A2 Positive Cells Present, Refractory Melanoma","enrollment":1},{"nctId":"NCT05488847","phase":"PHASE4","title":"Opioid-Free Pain Protocol After Shoulder Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-25","conditions":"Shoulder Arthropathy, Shoulder Pain","enrollment":83},{"nctId":"NCT01881048","phase":"EARLY_PHASE1","title":"Window of Opportunity Study Targeting the Inflammatory Milieu","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2009-12-08","conditions":"Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer","enrollment":42},{"nctId":"NCT07174570","phase":"PHASE2","title":"Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-01-02","conditions":"Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8","enrollment":39},{"nctId":"NCT06076837","phase":"PHASE1","title":"The Seven Trial: Exploiting the Unfolded Protein Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2025-01-09","conditions":"Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic","enrollment":6},{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT07171034","phase":"PHASE1","title":"A Phase I Study of KLA318-2 Nanocrystal Injection","status":"RECRUITING","sponsor":"Hunan Kelun Pharmaceutical Co., Ltd.","startDate":"2025-09-01","conditions":"Healthy Participants","enrollment":48},{"nctId":"NCT04786548","phase":"PHASE2","title":"Neuroinflammation in Patients With OCD","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2021-04-01","conditions":"Obsessive-Compulsive Disorder","enrollment":21},{"nctId":"NCT07221019","phase":"PHASE4","title":"Single Shot Exparel vs Catheters in Lower Extremity Trauma","status":"RECRUITING","sponsor":"George Washington University","startDate":"2025-09-12","conditions":"Fracture Dislocation of Ankle Joint, Fracture Leg, Fracture Femur","enrollment":90},{"nctId":"NCT03912428","phase":"PHASE1","title":"Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions","status":"TERMINATED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2019-06-14","conditions":"Myositis, Inflammatory, Rheumatoid Arthritis","enrollment":31},{"nctId":"NCT04814355","phase":"PHASE4","title":"The Effect of Celecoxib on Neuroinflammation in MDD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stony Brook University","startDate":"2018-08-01","conditions":"Major Depressive Disorder, Neuroinflammation","enrollment":42},{"nctId":"NCT07139405","phase":"PHASE2","title":"TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT","status":"NOT_YET_RECRUITING","sponsor":"Myopharm Limited","startDate":"2026-02","conditions":"Type 2 Diabetes (T2DM)","enrollment":90},{"nctId":"NCT07104266","phase":"PHASE2","title":"Triple Negative Breast Cancer and Celecoxib. Pilot Study","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-08-04","conditions":"Triple-Negative Breast Cancer","enrollment":30},{"nctId":"NCT05017246","phase":"PHASE2","title":"Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2022-01-18","conditions":"Cancer Debulking, Enlarged Uterus, Fibroid Uterus","enrollment":110},{"nctId":"NCT06699966","phase":"PHASE4","title":"Stony Brook Medicine Anti-Inflammatory Trial","status":"NOT_YET_RECRUITING","sponsor":"Stony Brook University","startDate":"2026-01","conditions":"Major Depressive Disorder","enrollment":42},{"nctId":"NCT06245109","phase":"PHASE4","title":"Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-02-26","conditions":"Knee Osteoarthritis","enrollment":180},{"nctId":"NCT06997068","phase":"PHASE2","title":"Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-09","conditions":"Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma, Stage IVC Lip and Oral Cavity Cancer AJCC v8","enrollment":25},{"nctId":"NCT05756166","phase":"PHASE1, PHASE2","title":"Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-02-16","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast Carcinoma","enrollment":5},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT05965492","phase":"PHASE3","title":"Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery","status":"WITHDRAWN","sponsor":"University of Miami","startDate":"2024-06-01","conditions":"Spinal Disorder","enrollment":""},{"nctId":"NCT05050409","phase":"NA","title":"SMART Embedded Intervention for Military Postsurgical Engagement Readiness","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-05-01","conditions":"Knee Pain Chronic","enrollment":500},{"nctId":"NCT06340932","phase":"","title":"Impact of Opioid Avoidance Protocol for ACL Reconstruction","status":"COMPLETED","sponsor":"Matthew Varacallo","startDate":"2024-04-27","conditions":"ACL Tear, Post Operative Pain","enrollment":32},{"nctId":"NCT02030964","phase":"PHASE1","title":"N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2014-01-16","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT04041050","phase":"PHASE1","title":"A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2019-11-08","conditions":"Myeloproliferative Neoplasm","enrollment":85},{"nctId":"NCT05974501","phase":"PHASE4","title":"Pre vs Post Block in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"University of Miami","startDate":"2023-09-29","conditions":"Knee Osteoarthritis, Arthroplasty Complications, Postoperative Pain","enrollment":84},{"nctId":"NCT04162873","phase":"PHASE2","title":"Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer","status":"TERMINATED","sponsor":"University of Utah","startDate":"2019-11-27","conditions":"Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Nasal Cavity and Paranasal Sinus Carcinoma","enrollment":13},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT05281276","phase":"PHASE1","title":"Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)","status":"TERMINATED","sponsor":"Taipei Medical University Shuang Ho Hospital","startDate":"2022-09-20","conditions":"Metastatic Colorectal Cancer","enrollment":9},{"nctId":"NCT04176419","phase":"PHASE3","title":"Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2020-01-17","conditions":"Postoperative Pain Control, Opioid Consumption","enrollment":30},{"nctId":"NCT04147013","phase":"PHASE4","title":"Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-02-18","conditions":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","enrollment":44},{"nctId":"NCT04765644","phase":"PHASE4","title":"Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-06-10","conditions":"Healthy","enrollment":44},{"nctId":"NCT05434065","phase":"PHASE2","title":"Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2023-01-01","conditions":"Intracerebral Hemorrhage","enrollment":60},{"nctId":"NCT03859024","phase":"PHASE4","title":"Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-03-22","conditions":"Pain, Postoperative, Urethral Stricture","enrollment":48},{"nctId":"NCT00151476","phase":"","title":"Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients","status":"TERMINATED","sponsor":"Pfizer","startDate":"2004-11","conditions":"Familial Adenomatous Polyposis (FAP)","enrollment":68},{"nctId":"NCT05077969","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","status":"TERMINATED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT04015908","phase":"PHASE4","title":"A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery","status":"COMPLETED","sponsor":"University of Utah","startDate":"2019-08-01","conditions":"Opioid Use","enrollment":100},{"nctId":"NCT02641314","phase":"PHASE2","title":"Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2016-12-22","conditions":"Recurrent Neuroblastoma","enrollment":18},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT06337422","phase":"PHASE1","title":"Bioequivalence Study of Generic Celecoxib 200 mg Capsules","status":"NOT_YET_RECRUITING","sponsor":"International Bio service","startDate":"2024-09-23","conditions":"Healthy Volunteer","enrollment":40},{"nctId":"NCT03818919","phase":"PHASE2","title":"Nonopioid Analgesia After Rotator Cuff Repair","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2019-01-22","conditions":"Rotator Cuff Tear","enrollment":70},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT03878524","phase":"PHASE1","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2020-04-01","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia","enrollment":2},{"nctId":"NCT02667730","phase":"PHASE4","title":"Correlation Between Acute Analgesia and Long-Term Function Following Ankle Injuries","status":"COMPLETED","sponsor":"Canadian Department of National Defence","startDate":"2015-06","conditions":"Ligament Injury","enrollment":168},{"nctId":"NCT01344200","phase":"PHASE2","title":"CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children","status":"RECRUITING","sponsor":"Children's Hospital of Eastern Ontario","startDate":"2024-01-29","conditions":"Pharmacokinetics of Celecoxib in Children","enrollment":65},{"nctId":"NCT05288374","phase":"PHASE4","title":"Celecoxib in Postoperative Analgesia for Radius Fracture Surgery","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2022-02-10","conditions":"Pain, Postoperative","enrollment":42},{"nctId":"NCT02502006","phase":"PHASE1","title":"Variability in Response to Non-steroidal Anti-inflammatory Drugs","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2015-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT03331315","phase":"PHASE2","title":"Toradol v. Celecoxib for Postoperative Pain","status":"COMPLETED","sponsor":"Michael Ulm, MD","startDate":"2013-09-01","conditions":"Pain, Postoperative","enrollment":170},{"nctId":"NCT03820193","phase":"EARLY_PHASE1","title":"Nonopioid Analgesia After Arthroscopic Meniscus Surgery","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2019-01-22","conditions":"Meniscus Disorder, Narcotic Use","enrollment":61},{"nctId":"NCT02688400","phase":"PHASE3","title":"Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"TRB Chemedica International SA","startDate":"2016-05","conditions":"Osteoarthritis, Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT05512013","phase":"PHASE1","title":"The Effects of NSAIDs on Bone Metabolism Following Exercise","status":"COMPLETED","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2022-02-15","conditions":"Bone Resorption, Stress Fracture, Bone Injury","enrollment":12},{"nctId":"NCT02739035","phase":"PHASE4","title":"MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-04","conditions":"Stiffness Following Total Knee Arthroplasty","enrollment":130},{"nctId":"NCT01545141","phase":"PHASE1, PHASE2","title":"Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2012-10","conditions":"Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors","enrollment":15},{"nctId":"NCT03949673","phase":"PHASE2","title":"Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip","status":"TERMINATED","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-04-08","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":23},{"nctId":"NCT03638297","phase":"PHASE2","title":"PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2018-08-23","conditions":"Colorectal Cancer","enrollment":29},{"nctId":"NCT05085574","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","status":"WITHDRAWN","sponsor":"Leidos Life Sciences","startDate":"2023-02-07","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":""},{"nctId":"NCT04788654","phase":"PHASE3","title":"Multimodal Analgesia for Cholecystectomy","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2021-03-17","conditions":"Laparoscopic Cholecystectomy","enrollment":60},{"nctId":"NCT00665457","phase":"PHASE2","title":"Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2004-04-15","conditions":"Breast Cancer","enrollment":3},{"nctId":"NCT04081389","phase":"PHASE1","title":"Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2019-12-06","conditions":"Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8","enrollment":9},{"nctId":"NCT00846430","phase":"PHASE2","title":"Medical Treatment of \"High-Risk\" Neurofibromas","status":"COMPLETED","sponsor":"Corewell Health West","startDate":"2008-10","conditions":"Neurofibromatosis 1","enrollment":9},{"nctId":"NCT04429022","phase":"PHASE3","title":"Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2020-11-24","conditions":"Pain, Postoperative","enrollment":68},{"nctId":"NCT05555823","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib","status":"COMPLETED","sponsor":"Atriva Therapeutics GmbH","startDate":"2022-06-23","conditions":"Healthy","enrollment":96},{"nctId":"NCT03599453","phase":"EARLY_PHASE1","title":"Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2019-01-09","conditions":"Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative","enrollment":8},{"nctId":"NCT05930080","phase":"PHASE3","title":"Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2021-01-28","conditions":"Osteoarthritis, Knee","enrollment":278},{"nctId":"NCT05237297","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2022-02-17","conditions":"Drug Interaction Potentiation","enrollment":72},{"nctId":"NCT05911126","phase":"NA","title":"How to Reduce Pain in Patients Undergoing Office Hysteroscopy.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-13","conditions":"Pain","enrollment":180},{"nctId":"NCT03563690","phase":"NA","title":"Different Kinds of Acupuncture Treatment for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Zhejiang Chinese Medical University","startDate":"2018-07-03","conditions":"Knee Osteoarthritis","enrollment":360},{"nctId":"NCT00538031","phase":"PHASE2","title":"Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2003-12-22","conditions":"Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer","enrollment":52},{"nctId":"NCT00268476","phase":"PHASE2, PHASE3","title":"Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical Research Council","startDate":"2005-07-08","conditions":"Prostate Cancer","enrollment":11992},{"nctId":"NCT03304379","phase":"PHASE3","title":"Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2017-10-26","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":1650},{"nctId":"NCT01765296","phase":"PHASE3","title":"Phase III Study of CG100649 in Osteoarthritis Patients","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2013-03","conditions":"Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee","enrollment":362},{"nctId":"NCT00503035","phase":"PHASE2","title":"Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2003-08-20","conditions":"Familial Adenomatous Polyposis","enrollment":51},{"nctId":"NCT01341405","phase":"PHASE2","title":"Study of CG100649 Versus Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2011-04","conditions":"Osteoarthritis","enrollment":125},{"nctId":"NCT05648916","phase":"","title":"Celebrex and HO Study","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2022-08-02","conditions":"Heterotopic Ossification","enrollment":200},{"nctId":"NCT03403634","phase":"PHASE2","title":"Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2018-04-19","conditions":"Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7","enrollment":19},{"nctId":"NCT01554163","phase":"PHASE3","title":"Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-03","conditions":"Osteoarthritis of the Knee","enrollment":239},{"nctId":"NCT01572675","phase":"","title":"A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-06","conditions":"Osteoarthritis","enrollment":547},{"nctId":"NCT02054104","phase":"PHASE1, PHASE2","title":"Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-09-03","conditions":"Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura","enrollment":21},{"nctId":"NCT02726659","phase":"PHASE3","title":"Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2016-05","conditions":"Bipolar Disorder, Postpartum Depression","enrollment":1},{"nctId":"NCT03465280","phase":"","title":"Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)","status":"UNKNOWN","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2018-04-01","conditions":"Recurrent Respiratory Papillomatosis, Human Papilloma Virus","enrollment":400},{"nctId":"NCT00112502","phase":"PHASE2","title":"Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2005-09","conditions":"Brain and Central Nervous System Tumors, Glioblastoma Multiforme","enrollment":178},{"nctId":"NCT03351439","phase":"NA","title":"Efficacy of Multimodal Analgesia Following Hip Arthroscopy","status":"COMPLETED","sponsor":"Western University, Canada","startDate":"2018-04-06","conditions":"Hip Pain Chronic","enrollment":100},{"nctId":"NCT04505657","phase":"NA","title":"Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":150},{"nctId":"NCT03586934","phase":"PHASE3","title":"Multimodal Analgesia in Shoulder Arthroplasty","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2018-06-01","conditions":"Shoulder Pain, Opioid Use","enrollment":""},{"nctId":"NCT03121963","phase":"PHASE4","title":"Pain Management in Head and Neck Surgery Patients","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2017-11-10","conditions":"Pain Management","enrollment":""},{"nctId":"NCT03472469","phase":"PHASE4","title":"MAST Trial: Multi-modal Analgesic Strategies in Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Nonspecific Pain Post Traumatic Injury","enrollment":1561},{"nctId":"NCT00359151","phase":"PHASE4","title":"Celebrex Total Knee Arthroplasty Study","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-11","conditions":"Osteoarthritis, Pain","enrollment":22},{"nctId":"NCT00290901","phase":"PHASE4","title":"Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-03","conditions":"Back Pain","enrollment":754},{"nctId":"NCT00137033","phase":"PHASE4","title":"Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-09","conditions":"Peptic Ulcers","enrollment":605},{"nctId":"NCT00163241","phase":"PHASE3","title":"Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-06","conditions":"Osteoarthritis","enrollment":666},{"nctId":"NCT00585312","phase":"PHASE3","title":"Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-09","conditions":"Adenomatous Polyposis Coli","enrollment":106},{"nctId":"NCT00630929","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-01","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00633386","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-02","conditions":"Arthroscopy","enrollment":200},{"nctId":"NCT00633438","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-01","conditions":"Arthroscopy","enrollment":204}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"ASTHENIA"},{"count":2,"reaction":"ARTHROPATHY"},{"count":2,"reaction":"CELLULITIS"},{"count":2,"reaction":"DIARRHOEA"},{"count":2,"reaction":"URINARY TRACT INFECTION"},{"count":2,"reaction":"VOMITING"},{"count":1,"reaction":"ABDOMINAL DISCOMFORT"},{"count":1,"reaction":"ABSCESS LIMB"},{"count":1,"reaction":"ANAL ABSCESS"},{"count":1,"reaction":"ANXIETY"}],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Celebrex","Chemotherapy, radiotherapy"],"phase":"marketed","status":"active","brandName":"Celecoxib (Celebrex)","genericName":"Celecoxib (Celebrex)","companyName":"National Eye Institute (NEI)","companyId":"national-eye-institute-nei","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}